October E-learn Call: Visual Design for Powerful Presentations Sophy Wong (East Bay AETC)

Objectives By the end of this session, participants will be able to: Discuss and practice using 3 visual presentation design principles Evaluate 2 example presentation slides and recommend 2 ways to increase their visual impact Create your own awesome, high-impact slide

for Powerful Presentations! Sophy Wong, MD

objectives process & principles slide makeover s design a good slide

simplicity

focus

objectives process & principles slide makeover s design a good slide

1. focus

high impact visuals

clear fonts

dark on light

(very) light on dark

empty space

2. repetition

same fonts same colors same design

slide master

Does this enhance my central point?

…or does this?

3. alignment

Keep it together text boxes tables grids

objectives process & principles slide makeover s design a good slide

bullet point makeover

Potential Benefits of Early Therapy (CD4 count >500 cells/µL)  Cohort study data show survival benefit if ART initiated at CD4 count >500 cells/µL  Earlier ART may prevent HIV-related end organ damage; deferred ART may not reliably repair damage acquired earlier  Increasing evidence of direct HIV effects on various end organs and indirect effects via HIV-associated inflammation  End organ damage occurs at all stages of infection October 2011www.aidsetc.org 32

Potential Benefits of Early Therapy (CD4 count >500 cells/µL) (2)  Potential decrease in risk of many complications, including:  HIV-associated nephropathy  Liver disease progression from hepatitis B or hepatitis C  Cardiovascular disease  Malignancies (AIDS defining and non-AIDS defining)  Neurocognitive decline  Blunted immunological response owing to ART initiation at older age  Persistent T-cell activation and inflammation October 2011www.aidsetc.org 33

Potential Benefits of Early Therapy (CD4 count >500 cells/µL) (3)  Prevention of sexual and bloodborne transmission of HIV  Prevention of mother-to-child transmission of HIV October 2011www.aidsetc.org 34

Potential Limitations of Early Therapy (CD4 count >500 cells/µL)  ARV-related toxicities  Drug resistance  Nonadherence to ART  Cost October 2011www.aidsetc.org 35

When to start ↑ CD4 +stay healthy  transmissio n -adherence  OIs -drug toxicity -resistance -lack of options

graph makeover

Source: Centers for Disease Control and Prevention (CDC). eHARS. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, [ ]. Percentage of Newly Reported HIV (non-AIDS) Cases By Race/Ethnicity, Alameda County

HIV by race/ethnicity, 2008

CA hep C treatment algorithm: handout! Getty Images

Shutterstock.com

CA hep C treatment algorithm mild liver disease wait cirrhosis, cryos vasculitis IFN-ineligible: SOF+Rib x24wks IFN-eligible: SOF+Rib+IFN X12wks

objectives process & principles slide makeover s design a good slide

1. master slide 2. title slide 3. data slide

start fresh & focus

Questions?

Contact Any questions about the presentation:  Sophy Wong: